Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 1Phase 1/2 1

Status

Completed 4Withdrawn 2Not yet recruiting 2

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Pancreatic Neoplasms 8Liver Neoplasms 5Carcinoma, Hepatocellular 4Lung Neoplasms 3Squamous Intraepithelial Lesions 2Prostatic Neoplasms 2Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Urinary Bladder Neoplasms 1Ureteral Neoplasms 1Unresectable Pancreatic Cancer 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Small Cell Lung Carcinoma 1Skin Neoplasms 1Rectal Neoplasms 1Pancreatic Ductal Adenocarcinoma 1Neoplasm Metastasis 1Melanoma 1Lymphatic Metastasis 1Liver, Cancer of, Non-Resectable 1Laryngeal Neoplasms 1Hilus Pulmonary Neoplasms 1Head and Neck Neoplasms 1HIV Seropositivity 1Gallbladder Neoplasms 1Extremities Neoplasms 1Esophageal Neoplasms 1Colorectal Liver Metastases 1Carcinoma, Renal Cell 1

Interventions

Sorafenib 121Nivolumab 36pembrolizumab 32Bevacizumab 28lenvatinib 27Doxorubicin 23Radiosurgery 21Radiofrequency Ablation 20Oxaliplatin 20Hepatectomy 18Fluorouracil 15Capecitabine 15Magnetic Resonance Spectroscopy 14atezolizumab 13Leucovorin 13Cisplatin 13Gemcitabine 11Erlotinib Hydrochloride 11tislelizumab 9Sirolimus 9Radiotherapy 9Irinotecan 9Ipilimumab 9cabozantinib 8Liver Transplantation 8regorafenib 7Ramucirumab 7Folfox protocol 7Embolization, Therapeutic 7sintilimab 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Carcinoma, Hepatocellular × Electroporation × Clear all
NCT03630640 2024-07-31

NIVOLEP

Assistance Publique - Hôpitaux de Paris

Phase 2 Completed
43 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT02828865 2020-07-07

A Clinical Trial Using Irreversible Electroporation for the Treatment of Liver Cancers

National Taiwan University Hospital

Phase NA Completed
18 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT03008343 2019-09-12

Combination of Irreversible Electroporation and NK Immunotherapy for Recurrent Liver Cancer

Fuda Cancer Hospital, Guangzhou

Phase 1/2 Completed
20 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT02010801 2013-12-13

Evaluation of Tumor Ablation Effects by Irreversible Electroporation for Patients With Malignant Liver Tumors

National Taiwan University Hospital

Phase NA Completed
20 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡